国际皮肤性病学杂志    2001 27 (4): 195-198   ISSN: 2096-5540  CN: 32-1880/R   抗真菌药物的协同作用 张正华综述, 刘维达审校 中国医学科学院、中国协和医科大学皮肤病研究所 收稿日期 null  修回日期 null  网络版发布日期 null 参考文献  [1] Sanders CC,Sanders WE Jr,Moland ES.Decimal assay for additivity of drugs permits delineation of synergy and antagonism.Antimicrob Agents Chemother,1993,37(2):260-264. [2] Polak A.Combination of amorolfine with various antifungal drugs in dermatophytosis.Mycoses,1993,36(1-2):43-49. [3] Baran R,Feuilhade M,Datry A,et al.A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.Br J Dermatol,2000,142(6):1177-1183. [4] Barchiesi F,Falconi Di Francesco L,Scaliso G.In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.Antiricrob Agents Chemother,1997,41(8):1812-1814. [5] Barchiesi F,Di Francesco LF,Compagnucei P,et al.In-vitro interaction of terbinafine with amphotericin B,fluconazole and itraconazole against clinical isolates of Candida albicans.J Antimicrob Chemother,1998,41(1):59-65. [6] Ryder NS.Activity of terbinafine against serious fungal pathogens.Mycoses,1999,42(Suppl 2):115-119. [7] Shenep JL,English K,Kaufnmn L,et al.Successful medical therapy for deeply invasive facial infection due to Pythiuminsidiosum.Clin Infect Dis,1999,27:1812-1814. [8] Sanyal AK,Roy D,Chowdhury B,et al.Ibuprofen,an unique anti-inflammatory compound activity against dermatophytes.Lett Appl Microbiol,1993,17:109-111. [9] Scott EM,Tariq VN,McCrory RM,et al.Demonstration of synergy with fluconazole and either ibuprofen,sodium salicylate,or propylparaben against Candida albicans in vitro.Antimicrob Agents Chemother,1995,39(12):2610-2614. [10] Tariq VN,Scott EM,McCain NE,et al.Use of decinal assay for additivity to demonstrate synergy in pair combinations of econazole,nikkomycin Z,and ibuprofen against Candida albicans in vitro.Antimicrob Agents Chemother,1995,39(12):2615-2619. [11] Hector RF,Schaller K.Positive interaction of nikkomycins and azoles against Candida albicans in vitro and in vivo.Antinicrob Agents Chemother,1992,36(6):1284-1289. [12] Li RK,Rinaldi MG.In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole.Antimicrob Agents Chemother,1999,43(6):1401-1405. [13] Yanmne N,Behiry IK,Tosaka M,et al.Determination of in vitro synergy when amphotericin B is combined with various antimicrobial agents against yeasts by using a colorimetric microdilution checkerboard.Rinsho Byori,1997,45(7):689-695. [14] Chin NX,Weitzman I,Della-Latta P.In vitro activity of fluvastatin,a cholesterol-lowering agent,and synergy with flucanazole and itraconazole against Caadida species and Cryptococus neoformans.Antimicrob Agents Chemother,1997,41(4):850-852. [15] McElhaney-Feser GE,Raulli RE,Cihlar RL.Synergy of nitric oxide and azoles against Canadida species in vitro.Antimicrob Agents Chemother,1998,42(9):2342-2346. [16] Kuipers ME,de Vries HG,Eikelboom MC,et al.Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates.Antimicrob Agents Chemother,1999,43 (11):2635-2641. [17] Nguyen MH,Barchiesi F,McGough DA,et al.In vitro evaluation of combination of fluconazole and flucytosine against Cryptocoaus neoformans var.neoformmanas.Antimicrob Agents Chemother,1995,39 (8):1691-1695. [18] Barchiesi F,Gallo D,Caselli F,et al.In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.J Antimicrob Chemother,1999,44(1):65-70. [19] Barchiesi F,Schimizzi AM,Caselli F,et al.Interactions between triazoles and amphotericin B against Cryptococcus neoformans.Antimicrob Agents Chemother,2000,44(9):2435-2441. [20] Ribner B,Keusch GT,Hanna BA,et al.Combination amphotericin B-rifampin therapy for ptulmonary aspergillosis in a leukemic patient.Chest,1976,70(5):681-683. [21] Clancy CJ,Yu YC,Lewin A,et al.Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusariurm:demonstration of in vitro synergy between rifalutin and amphotericin B.Antimicrob Agents Chemother,1998,42(3):509-513. [22] Nguyen MH,Clancy CJ,Yu YC,et al.Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species.Eur J Clin Microbiol Infect Dis,1997,16(11):846-848. [23] Barrios NJ,Kirkpatrick DV,Murciano A,et al.Successful treatment of disseminated Fusarium infection in an immunocompmmised child.Am J Pediatr Hematol Oncol,1990,12(3):319-324. [24] Clancy CJ,Nguyen MH.The combination of amphotericin B and azithromycin as a potential new therapeutic approach to fuariosis.J Antimicrob Chemother,1998,41(1):127-130. [25] Clancy CJ,Wingard JR,Hong Nguyen M.Subcutaneous phaeohyomycosis in transplant recipients:review of the luterature and demonstration of in vitro synergy between antifungal agents.Med Mycol,2000,38(2):169-175. 通讯作者: